Pliant Therapeutics, Inc.PLRXNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank63
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P63
Within normal range
Average
-1400.27%
Historical baseline
PeriodValueYoY Change
20250.00%-
20240.00%+100.0%
2023-10014.43%-716.1%
2022-1227.15%+2.9%
2021-1264.24%-1210.7%
2020-96.46%-46535.7%
2019-0.21%-
20180.00%-
20170.00%-